Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis

by Dranitsaris G, Shane LG, Crowther M, Feugere G, Woodruff S
Published 2017-01-01

Drug tendering: drug supply and shortage implications for the uptake of biosimilars

by Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG
Published 2017-09-01

Patient attitudes and understanding about biosimilars: an international cross-sectional survey

by Jacobs I, Singh E, Sewell KL, AL-Sabbagh A, Shane LG
Published 2016-05-01